PRDM1 Antibody / BLIMP1

NSJ Bioreagents
Product Code: NSJ-V5177
Product Group: Primary Antibodies
Supplier: NSJ Bioreagents
CodeSizePrice
NSJ-V5177-20UG20 ug£264.00
Quantity:
NSJ-V5177-100UG100 ug£534.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: Mouse IgG2a
Antibody Clonality: Monoclonal
Antibody Clone: PCRP-PRDM1-2B9
Regulatory Status: RUO
Target Species: Human
Applications:
  • Fluorescence-activated cell sorting (FACS)
  • Immunofluorescence (IF)
Storage:
Aliquot the BLIMP-1 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Images

1 / 2
Immunofluorescent staining of PFA-fixed human HeLa cells with PRDM1 antibody (green, clone PCRP-PRDM1-2B9) and CF640R phalloidin (red).~
2 / 2
Flow cytometry testing of PFA-fixed human HeLa cells with PRDM1 antibody (clone PCRP-PRDM1-2B9) follow

Immunofluorescent staining of PFA-fixed human HeLa cells with PRDM1 antibody (green, clone PCRP-PRDM1-2B9) and CF640R phalloidin (red).~
Flow cytometry testing of PFA-fixed human HeLa cells with PRDM1 antibody (clone PCRP-PRDM1-2B9) follow

Documents

Further Information

Application Details:
Flow cytometry: 1-2ug/million cells,Immunofluorescence: 1-2ug/ml
Description:
The development and differentiation of plasma cells, which are terminally differentiated B-cells, are induced by Blimp-1 (B lymphocyte-induced maturation protein, also designated PRDI-BF1). Blimp-1 is a transcriptional repressor that localizes to the nucleus and is considered a master regulator of terminal B-cell development. Alone, Blimp-1 is sufficient to trigger terminal B-cell differentiation. Blimp-1 upregulates the expression of syndecan-1 and J chain, represses IFN-b gene transcription and associates with HDAC to recruit it to DNA, thereby repressing c-Myc. Blimp-1 is expressed during the late stages of B-cell differentiation in immunoglobulin-secreting plasma cells, as well as in long-lived, bone marrow plasma cells. The expression of Blimp-1 defines a checkpoint beyond which fully activated B cells proceed to the plasma cell stage, whereas immature and partially activated cells are eliminated.
Format:
Purified
Formulation:
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Immunogen:
Recombinant full-length human protein was used as the immunogen for the BLIMP-1 antibody.
Limitation:
This BLIMP-1 antibody is available for research use only.
Localization:
Nucleus, Cytoplasm
Purity:
Protein A/G affinity
Uniprot #:
O75626